Severe pediatric asthma therapy: Omalizumab—A systematic review and meta-analysis of efficacy and safety profile
BackgroundOmalizumab is the first biological therapy used to treat moderate-to-severe asthma and certainly the one with the highest number of publications.MethodsA systematic review and meta-analysis were performed to examine two critical outcomes of omalizumab therapy, asthma exacerbation rate, the...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Pediatrics |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fped.2022.1033511/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|